Symbol="MRSN"
AssetType="Common Stock"
Name="Mersana Therapeutics Inc"
Description="Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of Antibody Drug Conjugates (ADCs) for cancer patients with unmet needs. The company is headquartered in Cambridge, Massachusetts."
CIK="1442836"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="840 MEMORIAL DRIVE, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="422084000"
EBITDA="-213975008"
PERatio="None"
PEGRatio="0"
BookValue="0.59"
DividendPerShare="0"
DividendYield="0"
EPS="-2.21"
RevenuePerShareTTM="0.322"
ProfitMargin="0"
OperatingMarginTTM="-6.65"
ReturnOnAssetsTTM="-0.485"
ReturnOnEquityTTM="-2.081"
RevenueTTM="32347000"
GrossProfitTTM="-146804000"
DilutedEPSTTM="-2.21"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.832"
AnalystTargetPrice="11.29"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="57.83"
PriceToBookRatio="7.14"
EVToRevenue="32.87"
EVToEBITDA="-1.917"
Beta="1.536"
num_52WeekHigh="9.62"
num_52WeekLow="2.975"
num_50DayMovingAverage="5.78"
num_200DayMovingAverage="5.91"
SharesOutstanding="114386000"
DividendDate="None"
ExDividendDate="None"
symbol="MRSN"
open="3.66"
high="3.88"
low="3.65"
price="3.86"
volume="1578582.00"
latest_trading_day="2023-07-25"
previous_close="3.69"
change="0.17"
change_percent="4.6070%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="71"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="29"
Volume_recent_avg="2583361"
Change_recent_avg="0.03"
Delta_recent_avg="0.38"
Variance_recent_avg="0.19"
Change_ratio_recent_avg="0.23"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="29"
Aroon_momentum_negative="71"
image_negative_thumbnail_id_1="118"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0058.jpeg"
image_negative_thumbnail_id_2="1086"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0119.jpeg"
image_neutral_thumbnail_id_1="567"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_neutral_thumbnail_id_2="537"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_positive_thumbnail_id_1="1009"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0171.jpeg"
image_positive_thumbnail_id_2="997"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0159.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
